Skip to main content
. 2019 Aug 31;146(11):2968–2978. doi: 10.1002/ijc.32629

Figure 2.

Figure 2

Kaplan–Meier curves for the treatment and control groups for pooled population 1 (a) and the curves for fluoropyrimidine combined with oxaliplatin compared to fluoropyrimidine monotherapy in pooled population 2 (b).